Rotter V - Search Results

1

Direct involvement of p53 in programmed cell death of oligodendrocytes.

Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M. Eizenberg O, et al. Among authors: rotter v. EMBO J. 1995 Mar 15;14(6):1136-44. doi: 10.1002/j.1460-2075.1995.tb07097.x. EMBO J. 1995. PMID: 7720704 Free PMC article.

2

Mutant p53 gain-of-function in cancer.

Oren M, Rotter V. Oren M, et al. Among authors: rotter v. Cold Spring Harb Perspect Biol. 2010 Feb;2(2):a001107. doi: 10.1101/cshperspect.a001107. Cold Spring Harb Perspect Biol. 2010. PMID: 20182618 Free PMC article. Review.

3

p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells.

Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V, Schwartz M. Eizenberg O, et al. Among authors: rotter v. Mol Cell Biol. 1996 Sep;16(9):5178-85. doi: 10.1128/MCB.16.9.5178. Mol Cell Biol. 1996. PMID: 8756675 Free PMC article.

4

Introduction: p53--the first twenty years.

Oren M, Rotter V. Oren M, et al. Among authors: rotter v. Cell Mol Life Sci. 1999 Jan;55(1):9-11. doi: 10.1007/s000180050265. Cell Mol Life Sci. 1999. PMID: 10065147 Review.

5

Targeting mutant p53 for cancer therapy.

Oren M, Tal P, Rotter V. Oren M, et al. Among authors: rotter v. Aging (Albany NY). 2016 Jun;8(6):1159-60. doi: 10.18632/aging.100992. Aging (Albany NY). 2016. PMID: 27347904 Free PMC article. No abstract available.

6

Inhibition of cell growth mediated by plasmids encoding p53 anti-sense.

Shohat O, Greenberg M, Reisman D, Oren M, Rotter V. Shohat O, et al. Among authors: rotter v. Oncogene. 1987;1(3):277-83. Oncogene. 1987. PMID: 2455263

7

Meth A fibrosarcoma cells express two transforming mutant p53 species.

Eliyahu D, Goldfinger N, Pinhasi-Kimhi O, Shaulsky G, Skurnik Y, Arai N, Rotter V, Oren M. Eliyahu D, et al. Among authors: rotter v. Oncogene. 1988 Sep;3(3):313-21. Oncogene. 1988. PMID: 3060794

8

Targets for transcriptional activation by wild-type p53: endogenous retroviral LTR, immunoglobulin-like promoter, and an internal promoter of the mdm2 gene.

Barak Y, Lupo A, Zauberman A, Juven T, Aloni-Grinstein R, Gottlieb E, Rotter V, Oren M. Barak Y, et al. Among authors: rotter v. Cold Spring Harb Symp Quant Biol. 1994;59:225-35. doi: 10.1101/sqb.1994.059.01.027. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587074 No abstract available.

9

Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif.

Ragimov N, Krauskopf A, Navot N, Rotter V, Oren M, Aloni Y. Ragimov N, et al. Among authors: rotter v. Oncogene. 1993 May;8(5):1183-93. Oncogene. 1993. PMID: 8479742

10

Repression of the MSP/MST-1 gene contributes to the antiapoptotic gain of function of mutant p53.

Zalcenstein A, Weisz L, Stambolsky P, Bar J, Rotter V, Oren M. Zalcenstein A, et al. Among authors: rotter v. Oncogene. 2006 Jan 19;25(3):359-69. doi: 10.1038/sj.onc.1209061. Oncogene. 2006. PMID: 16170349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page